Antidepressant may slow Alzheimer’s disease
Antidepressants can reduce production of the main ingredient of Alzheimer’s brain plaques, according to new research at Washington University School of Medicine in St. Louis and the University of Pennsylvania. The plaques are highlighted in red in this image of a mouse’s brain.
Alzheimer’s brain change measured in humans
Scientists at the School of Medicine have measured a significant and potentially pivotal
difference between the brains of patients with an inherited form of
Alzheimer’s disease and healthy family members who do not carry the
mutation. Randall Bateman, MD, is the study’s senior author.
Alzheimer’s patients can’t effectively clear sticky plaque component
Neurologists finally have an answer to one of the most important questions about Alzheimer’s disease: Do rising brain levels of a plaque-forming substance mean patients are making more of it or that they can no longer clear it from their brains as effectively? A new study by Randall Bateman, MD, assistant professor of neurology, shows clearance is impaired in Alzheimer’s patients.
New model suggests feared side effect of Alzheimer’s drugs is unlikely
The first trial of a new model for testing Alzheimer’s treatments has reassured researchers that a promising class of drugs does not exacerbate the disease if treatment is interrupted.
Three medical school faculty to be honored by Academy of Science of St. Louis
Three faculty members of the School of Medicine will be honored by the Academy of Science of St. Louis: Randall Bateman, M. Carolyn Baum and Alan L. Schwartz.